Facebook
X
LinkedIn
Forward
Advanced Pharmacology at the Edge of Care: Precision, Pragmatism, and Palliative Reality
This workshop offers participants a self-guided learning material alongside a 6-hour live virtual an in-depth exploration of CAMP (Complementary and Alternative Pharmaceuticals), end of life pharmacological treatment, patient substance abuse, and a perspective on the dynamic use of buprenorphine in hospice and palliative care. With over 5 hours of accredited learning, this course is specifically designed for advanced clinicians and those professionals with prescribing privileges with the goal of providing an enhanced understanding of drug therapy principles and their clinical applications.
Session Outline
Sessions listed in Central Time
| Time | Session | Faculty |
|---|---|---|
| 10:05 am - 11:25 am | Not Harmless, Not Hopeless: Complementary Pharmaceuticals in Palliative Care | Dr. Mary Lynn McPherson |
| 11:40 am - 1:00 pm | Psychopharmacology at the End of Life: Choosing the Right Drug for the Right Moment | Dr. Jeremy Hirst |
| 1:00 pm - 2:20 pm | From OUD to Analgesia: Buprenorphine’s Expanding Role in Serious Illness | Dr. Marcin Chwistek Dr. Mellar P. Davis |
| 2:35 pm - 3:55 pm | Care at the Crossroads: An Approach to Patients with Advanced Illness who Use Substances | Dr. Julie Childers |
Target Audience
This course is specifically designed for advanced clinicians and professionals with prescribing privileges, but we encourage all interdisciplinary HPM care professionals to attend, including:
- Physicians
- Advanced Practice Providers
- Nurses
- Pharmacists
- Other clinicians responsible for symptom management in seriously ill patients.
Learning Outcomes
By the end of this workshop, participants will be able to:
- Apply complex pharmacologic principles to make informed prescribing decisions for patients with serious illness, including drug selection, dosing and delivery.
- Evaluate and adjust maintenance medication regimens at end of life based on prognosis, symptom burden, and patient goals to optimize safety and effectiveness.
- Identify strategies to balance pain control with management of addiction in patients with advanced illness.
- Develop a practical approach to initiating, rotating to, and managing buprenorphine for analgesia in palliative care populations, including patients with multimorbidity, renal impairment, prior to full-agonist exposure, and concurrent opioid use disorder.
Activity summary
- 5.25 ABIM MOC
- 5.25 CME (physician only)
- 5.25 Participation
Disclosures
AAHPM endorses the Accreditation Council for Continuing Medical Education (ACCME) Standards for disclosure and commercial support and endeavors to ensure balance, independence, objectivity, and scientific rigor for all accredited products or programs. All who are in a position to control or influence the content of an educational activity must disclose any relevant financial relationships with ineligible companies.*Disclosure documents were reviewed for potential conflicts of interest and, if identified, were resolved prior to confirmation of participation. Only those who had no conflict of interest or who agreed to an identified resolution process prior to their participation were involved in this activity.
All editors, faculty and staff have disclosed no relevant financial relationships.
*An ineligible company is defined as any entity producing, marketing, reselling, or distributing healthcare goods or services consumed by, or used on, patients.
Faculty
Mary Lynn McPherson, PharmD PhD FAAHPM
Jeremy Hirst, MD
Julie Childers, MD
Marcin Chwistek, MD FAAHPM
Mellar P. Davis, MD FCCP FAAHPM
Staff
Katie Siesel, BS
Emily Geary, BA
Krys Hansen, MS
Continuing Medical Education (CME)
The American Academy of Hospice and Palliative Medicine (AAHPM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Academy of Hospice and Palliative Medicine (AAHPM) designates this blended learning activity for a maximum of 5.25 AMA PRA Category 1 Credit(s)™.
Evaluation period closes June 30, 2027 for claiming CME credit.
Maintenance of Certification (MOC) Recognition Statement
Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory, Advanced Pharmacology at the Edge of Care: Precision, Pragmatism, and Palliative Reality applies toward general CME requirement for the following ABMS Member Boards:
- Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.25 MOC Medical Knowledge points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program.
- Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 5.25 MOC points in the American Board of Pediatrics' (ABP) Maintenance of Certification (MOC) program.
It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. By submitting your evaluation, you grant AAHPM permission to submit completion information to ACCME for the purpose of granting respective BOARD MOC program credit or points as applicable. De-identified aggregated data from the evaluation may be used for research and/or publication and will conform to generally accepted standards of experimental design, data collection and analysis where indicated.
Evaluation period closes June 30, 2027 for claiming MOC credit.
Available Credit
- 5.25 ABIM MOC
- 5.25 CME (physician only)
- 5.25 Participation